Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature
Rui Bao(Jiangsu University), Zhaofei Liu(Peking University), Jianhao Lai(Peking University), Jing Huang(Peking University), Zhi Yang(Peking University), Nan Li(Peking University Cancer Hospital), Fan Wang(Army Medical University), Yang Zhao(Guangxi Medical University), Suping Li(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Yanpu Wang(Peking University), Hua Zhu(Peking University)
Cited by 91
Related Papers
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
Precise nanomedicine for intelligent therapy of cancer
|Science China Chemistry|2018|413
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
|Nature Biotechnology|2024|258
Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity
|Journal of Controlled Release|2015|254